Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma.

Saved in:
Bibliographic Details
Title: Targeting Acetyl-CoA Carboxylase Suppresses De Novo Lipogenesis and Tumor Cell Growth in Multiple Myeloma.
Authors: Morelli E; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.; Department of Oncology, University of Torino, Candiolo, Italy., Ribeiro CF; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; New York, New York., Rodrigues SD; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; New York, New York., Gao C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Socciarelli F; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; New York, New York., Maisano D; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Favasuli V; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Liu N; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Todoerti K; Department of Diagnostic Innovation, IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Chakraborty C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Yao Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Blood Disease Institute, Key Laboratory of Bone Marrow Stem Cell, Xuzhou Medical University, Xuzhou, China., Fulciniti M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Samur M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Aktas-Samur A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Amodio N; Department of Clinical and Experimental Medicine, Magna Graecia University, Catanzaro, Italy., Turi M; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Barello F; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Penailillo J; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Giallongo C; Department of Medical, Surgical Sciences and Advanced Technologies 'G. F. Ingrassia', University of Catania, Catania, Italy., Romano A; Department of Surgery and Medical Specialties, University of Catania, Catania, Italy., Gulla A; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Anderson KC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Inghirami G; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; New York, New York., Munshi NC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; VA Boston Healthcare System, Boston, Massachusetts., Loda M; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; New York, New York.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Nuffield Department of Surgical Sciences, Lincoln College, University of Oxford, Oxford, United Kingdom.
Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 May 15; Vol. 31 (10), pp. 1975-1987.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first